Cargando…

PReS-FINAL-2178: Clinical and microarray follow-up of SJIA patients treated with anakinra over the past 10 years in a single institution

Detalles Bibliográficos
Autores principales:	Punaro, M, Gotte, A, Stoll, M, Blankenship, D, Allantaz, F, Xu, Z, Pascual, V
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4042531/ http://dx.doi.org/10.1186/1546-0096-11-S2-O13

Ejemplares similares

PReS-FINAL-2188: Insulin sensitivity is improved in sjia children with insulin resistance after tocilizumab treatment: results from the tender study
por: Mirjafari, H, et al.
Publicado: (2013)

An Economic Comparison of Treatment Strategies with Anakinra in Systemic Juvenile Idiopathic Arthritis (sJIA)
por: Bullement, Ash, et al.
Publicado: (2021)

IL-18 production upon s100 stimulation is reduced in active sJIA patients compared to sJIA patients in remission and healthy controls
por: Haar, Nienke Ter, et al.
Publicado: (2014)

PReS-FINAL-2156: Analysis of gene expression and inflammation biomarkers in systemic juvenile idiopathic arthritis (SJIA) patients on canakinumab therapy
por: Nirmala, N, et al.
Publicado: (2013)

PReS-FINAL-2140: Neutropenia with Tocilizumab (TCZ) treatment is not associated with increased infection risk in patients with systemic juvenile idiopathic arthritis (SJIA)
por: De Benedetti, F, et al.
Publicado: (2013)

PReS-FINAL-2040: Outcome of macrophage activation syndrom (MAS) in systemic juvenile idiopatic arthritis (SJIA) in non biologic treated patient
por: Lazarevic, DS, et al.
Publicado: (2013)

PReS-FINAL-2158: Effect of canakinumab on functional ability and health-related quality of life in systemic juvenile idiopathic arthritis (SJIA) patients
por: Quartier, P, et al.
Publicado: (2013)

PReS-FINAL-2366: Paediatric rheumatology in South Africa
por: Scott, C
Publicado: (2013)

PReS-FINAL-2367: Academic training of pediatric rheumatologist in the Russian federation
por: Alekseeva, E, et al.
Publicado: (2013)

2178 Drug development core facilitates institutional collaboration and translational science innovation
por: Morse, Gene, et al.
Publicado: (2018)

PReS-FINAL-2001: The impact of adalimumab on growth in patients with juvenile idiopathic arthritis
por: Ruperto, N, et al.
Publicado: (2013)

PReS-FINAL-2174: The performance of the new slicc criteria for the classification of sle in children
por: Sag, E, et al.
Publicado: (2013)

PReS-FINAL-2368: A, B, C, don't ever forget the joints
por: Abusrewil, W, et al.
Publicado: (2013)

PReS-FINAL-2194: Evidence-based clinical classification criteria for periodic fevers
por: Federici, S, et al.
Publicado: (2013)

PReS-FINAL-2179: Efficacy and safety of adalimumab in pediatric patients with enthesitis related arthritis
por: Burgos-Vargas, R, et al.
Publicado: (2013)

PReS-FINAL-2002: Adverse events during anti-TNF therapy in patients with JIA
por: Tarkiainen, M, et al.
Publicado: (2013)

PReS-FINAL-2185: Prognostic markers in juvenile vs. adult-onset ankylosing spondylitis
por: Jadon, D, et al.
Publicado: (2013)

PReS-FINAL-2134: Assessment of radiographic progression in patients (pts) with systemic juvenile idiopathic arthritis (sjia) treated with tocilizumab (TCZ): 2-year results from the tender trial
por: Malattia, C, et al.
Publicado: (2013)

Efficacy and safety of tocilizumab (TCZ) in patients with systemic juvenile idiopathic arthritis (sJIA): TENDER 52-week data
por: De Benedetti, Fabrizio, et al.
Publicado: (2012)

Predictors of response in patients with active systemic JIA (SJIA) receiving canakinumab: an exploratory analysis of pooled 12-week data
por: Ruperto, N, et al.
Publicado: (2014)

S100A12 as diagnostic tool in the differential diagnosis of sJIA associated MAS vs. hereditary or acquired HLH
por: Holzinger, D, et al.
Publicado: (2015)

PReS-FINAL-2186: Monoallelic mutations of familial hlh-related genes associated to macrophage activation syndrome
por: Bracaglia, C, et al.
Publicado: (2013)

PReS-FINAL-2182: The role of murine rage in innate immune responses and inflammation: a systematic approach
por: Wirth, T, et al.
Publicado: (2013)

PReS-FINAL-2173: Protein kinase C delta deficiency is a new cause of monogenic SLE
por: Belot, A, et al.
Publicado: (2013)

PReS-FINAL-2326: No correlation between anti-drug antibodies and pharmacokinetics, efficacy or safety of Anakinra (Kineret(®)) in patients with severe CAPS
por: Wikén, M, et al.
Publicado: (2013)

PReS-FINAL-2176: Declines in levels of disease activity and physical disability in children with juvenile idiopathic arthritis seen in standard clinical care over the last 25 years
por: Consolaro, A, et al.
Publicado: (2013)

PReS-FINAL-1020: Dysregulation of the peripheral blood D cell compartment is associated with disease activity in juvenile dermatomyositis
por: Piper, C, et al.
Publicado: (2013)

PReS-FINAL-2175: Pharmacokinetics of mycophenolate mofetil in children with lupus and clinical findings in favour of therapeutic drug monitoring
por: Woillard, JB, et al.
Publicado: (2013)

PReS-FINAL-2004: Musculoskeletal pain in schoolchildren across puberty: a 3-year follow-up study
por: Sperotto, F, et al.
Publicado: (2013)

PReS-FINAL-2191: Imaging of chronic recurrent multifocal osteitis: a french national cohort of 178 cases
por: Wipff, J, et al.
Publicado: (2013)

2178. Sensitivity of Blood Cultures in Detection of Bacteremia in Febrile Neutropenia
por: Patel, Vanisha, et al.
Publicado: (2019)

P02-029 - CAPS or SJIA
por: Alekseeva, E, et al.
Publicado: (2013)

Empirical use of anakinra in AA amyloidosis of uncertain aetiology
por: Lane, T, et al.
Publicado: (2015)

PReS-FINAL-2190: Validation of the new histopathological classification of anca glomerulonephritis and its association with renal outcomes in a paediatric population
por: Twilt, M, et al.
Publicado: (2013)

PReS-FINAL-2187: Use of screening tests in patients presenting to paediatric rheumatology with suspected haemophagocytic lymphohistiocytosis/macrophage activation syndrome
por: Cruikshank, M, et al.
Publicado: (2013)

PReS-FINAL-2052: Costs of biologics in juvenile idiopathic arthritis: past, present and future
por: Prince, FH, et al.
Publicado: (2013)

Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade
por: Pascual, Virginia, et al.
Publicado: (2005)

Insights into systemic lupus erythematosus pathogenesis through blood global gene expression analysis
por: Pascual, V, et al.
Publicado: (2004)

PReS-FINAL-2333: Long term efficacy of interleukin-1 receptor antagonist (anakinra) in a multicentric cohort of patients affected by idiopathic recurrent pericarditis
por: Finetti, M, et al.
Publicado: (2013)

PReS-FINAL-2193: Assessment of construct validity of new measures of global disease activity, physical function and quality of life in children with juvenile dermatomyositis
por: Ferrari, C, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_gfkb4tjasn05rdiaqjigrc8bub